「Generation of hypoimmunogenic T cells from genetically engineered allogeneic iPS cells for off-the-shelf cancer immunotherapy」の関連論文
-
Mini-TCRs: Truncated T cell receptors to generate T cells from induced pluripotent stem cells
-
Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cells
-
T cell receptor-engineered T cells derived from target human leukocyte antigen-DPB1-specific T cell can be a potential tool for therapy against leukemia relapse following allogeneic hematopoietic cell transplantation
-
Development of TCR-T cell therapy targeting mismatched HLA-DPB1 for relapsed leukemia after allogeneic transplantation
-
Isolation of TCR genes with tumor-killing activity from tumor-infiltrating and circulating lymphocytes in a tumor rejection cynomolgus macaque model
-
Polymorphic Region-Specific Antibody for Evaluation of Affinity-Associated Profile of Chimeric Antigen Receptor
-
Prognostic significance of plasma interleukin-6/-8 in pancreatic cancer patients receiving chemoimmunotherapy
-
Identification of T cell receptors targeting a neoantigen derived from recurrently mutated FGFR3
-
A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy
-
Preclinical evaluation of the efficacy of an antibody to human SIRPα for cancer immunotherapy in humanized mouse models
-
The therapeutic potential of multiclonal tumoricidal T cells derived from tumor infiltrating lymphocyte-derived iPS cells
-
Comprehensive analysis of TCR function using a novel system reveals the multiple unconventional tumor-reactive T cells in breast cancer-infiltrating lymphocytes
-
Enhanced anti-tumor effects of the PD-1 blockade combined with a highly absorptive form of curcumin targeting STAT3 (本文)
-
A novel cancer immunotherapy using tumor-infiltrating B cells in the APC (min/+) mouse model
-
A study on the immunostimulatory effects of alarmin HMGN1 in cancer immunity
-
The fruits of CD40 research in basic and clinical medicine will soon be harvested
-
Generation of molecular-targeting peptides for selective inhibition of the interaction between CTLA-4 and B7 in the dog: a new immune checkpoint inhibitor for cancer therapy
-
Editorial: Advances in Human Immune System Mouse Models for Studying Human Hematopoiesis and Cancer Immunotherapy
-
TLR-MyD88-signaling blockades inhibit refractory B-1b cell immune responses to transplant-related glycan antigens
-
TLR-MyD88-signaling blockades inhibit refractory B-1b cell immune responses to transplant-related glycan antigens
-
Re-generation of cytotoxic γδT cells with distinctive signatures from human γδT-derived iPSCs
-
Characterization of tumour-infiltrating lymphocytes in a tumour rejection cynomolgus macaque model.
-
Development of immunotherapy using antigen-loaded multifunctional small extracellular vesicles
-
A Potent CD1d-binding Glycolipid for iNKT-Cell-based Therapy Against Human Breast Cancer.
-
Local, multimodal intralesional therapy renders distant brain metastases susceptible to PD-L1 blockade in a preclinical model of triple-negative breast cancer.
-
A Clinically Applicable Prediction Model to Improve T Cell Collection in Chimeric Antigen Receptor T Cell Therapy
-
In situ vaccination using unique TLR9 ligand K3-SPG induces long-lasting systemic immune response and synergizes with systemic and local immunotherapy
-
iPSC screening for drug repurposing identifies anti‐RNA virus agents modulating host cell susceptibility
-
Compromised anti-tumor–immune features of myeloid cell components in chronic myeloid leukemia patients
-
Generation of macrophages with altered viral sensitivity from genome-edited rhesus macaque iPSCs to model human disease
-
Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response
-
Cell therapy for Parkinson's disease with induced pluripotent stem cells
-
Engineered Antibodies with Dual Inhibitory Activity against Toll-like Receptor Family Members
-
The therapeutic potential of multiclonal tumoricidal T cells derived from tumor infiltrating lymphocyte-derived iPS cells
-
Donor-derived M2 macrophages attenuate GVHD after allogeneic hematopoietic stem cell transplantation
-
Simple derivation of skeletal muscle from human pluripotent stem cells using temperature‐sensitive Sendai virus vector
-
A circulating subset of iNKT cells mediates antitumor and antiviral immunity
-
GPR64, Screened from Ewing Sarcoma Cells, Is a Potential Target for Antibody-Based Therapy for Various Sarcomas
-
Research for elucidation of immune evasion mechanisms and development of a novel immunotherapy for cancer in dogs [an abstract of entire text]
-
Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial
-
Oncolytic HSV-1 in combination with lenalidomide for plasma cell neoplasms
-
Study on the regulation of CD8+ T cell immune response through nuclear receptor RORα and REV-ERB [an abstract of entire text]
-
Metformin enhances the antitumor activity of oncolytic herpes simplex virus HF10 (canerpaturev) in a pancreatic cell cancer subcutaneous model
-
Lusutrombopag effectively promotes the growth and differentiation of megakaryocytic cells from patients with myelodysplastic syndrome
-
シグナル伝達抗体(Signalobody)を用いた細胞の運命制御系の開発
-
Stromal reaction inhibitor and immune-checkpoint inhibitor combination therapy attenuates excluded-type colorectal cancer in a mouse model
-
Stromal reaction inhibitor and immune-checkpoint inhibitor combination therapy attenuates excluded-type colorectal cancer in a mouse model
-
In vivo induction of activin A-producing alveolar macrophages supports the progression of lung cell carcinoma
-
Oncolytic activity of naturally attenuated herpes-simplex virus HF10 against an immunocompetent model of oral carcinoma
-
T-cell response to phytohemagglutinin in the interferon-γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non-small cell lung cancer
- 1
- 2